| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Dividendenbekanntmachungen (13.03.2026) | 6.971 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIAN ASSET MANAGEMENT INC US10948W1036 0,1 USD 0,0868 EUR ALBEMARLE CORPORATION US0126531013 0,405 USD 0,3516 EUR ALEXANDRIA... ► Artikel lesen | |
| Fr | EQT exits Galderma Group AG in full via largest sponsor-backed block trade ever | 2.241 | PR Newswire | EQT completes final sell-down in Galderma, a global dermatology company delivering science-backed solutions to healthcare professionals, consumers and patients worldwideUnder EQT's ownership... ► Artikel lesen | |
| Fr | Weekly Buzz: Bristol Myers Squibb Wins FDA Nod; EU Okays Johnson & Johnson's AKEEGA; Ipsen Withdraws Tazverik, Day One Biopharmaceuticals Acquired | 1.529 | AFX News | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed key FDA approvals, EU approvals, IND clearances, acquisitions, and clinical trial data readouts across key therapeutic areas... ► Artikel lesen | |
| Fr | Im Windschatten von Novo Nordisk: Dänisches Pharma-IPO voraus? | 727 | Der Aktionär | Dänemark und Pharma? In diesem Zusammenhang führt kein Weg an Novo Nordisk vorbei. Das Unternehmen, dessen Wurzeln bis ins Jahr 1923 reichen, war einst das wertvollste börsennotierte Unternehmen Europas.... ► Artikel lesen | |
| Fr | Novartis Pharma AG: Novartis Cosentyx receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa | 503 | GlobeNewswire (Europe) | Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade1-3 HS often emerges around puberty, underscoring importance of early diagnosis... ► Artikel lesen | |
| Fr | Promino Nutritional Sciences, Inc.: Promino Announces Proposed Private Placement | 480 | Newsfile | Burlington, Ontario--(Newsfile Corp. - March 13, 2026) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) ("Promino" or the "Company") announces that it intends to complete... ► Artikel lesen | |
| Fr | Numinus Wellness Inc.: Numinus Wellness Provides Corporate Update | 454 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 13, 2026) - Numinus Wellness Inc. (TSX: NUMI) (OTC: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral... ► Artikel lesen | |
| 08:36 | Psychische Erkrankungen im Visier: Wie Emyria und Newron die moderne Biotech-Therapie verändern | Small- & Micro Cap Investment | |||
| 09:11 | Extrem stark: Die jüngsten Entwicklungen übertreffen alle Erwartungen! | Inult | |||
| Fr | BioHarvest Sciences Inc.: BioHarvest Sciences Announces Grant of Long-Term Incentive Awards to Employees, Officers and Directors | 351 | Newsfile | Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - March 13, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) ("BioHarvest" or the "Company"), a company pioneering its patented Botanical... ► Artikel lesen | |
| Fr | GSK Says FDA Expands Arexvy RSV Vaccine Approved Age To Adults 18 To 49 Years At Increased Risk | 292 | AFX News | LONDON (dpa-AFX) - British drug major GSK plc (GSK, GSK.L) announced Friday that the US Food and Drug Administration or FDA, has expanded the approved age indication of Arexvy (Respiratory Syncytial... ► Artikel lesen | |
| Fr | European Commission Approves J&J Prostate Drug, PLX Fabry Dosing, Incyte's Zynyz Second Indication | 244 | AFX News | NEW BRUNSWICK (dpa-AFX) - The European Commission delivered notable regulatory decisions this week - expanding the indication for Johnson & Johnson's prostate cancer therapy, approving a new... ► Artikel lesen | |
| Fr | Wellgistics Health, Inc.: Wellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic Direction | 207 | ACCESS Newswire | TAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | Dividende 12M | Div.-Rendite | Erw. Dividende | Erw. Ex.-Datum | |
|---|---|---|---|---|---|---|
| PERRIGO | 8,152 | 0,98 | +12,02 % | 0,29 | 02.03.2026 | |
| PFIZER | 23,295 | 1,47 | +6,31 % | 0,43 | 23.01.2026 | |
| HIKMA PHARMACEUTICALS | 14,200 | 0,72 | +5,07 % | 0,36 | 19.03.2026 | |
| NOVO NORDISK | 33,400 | 1,57 | +4,70 % | 7,95 | 27.03.2026 | |
| BRISTOL-MYERS SQUIBB | 51,50 | 2,17 | +4,21 % | 0,63 | 02.04.2026 | |
| SHANGHAI PHARMACEUTICALS | 1,270 | 0,05 | +3,94 % | 0,13 | 29.12.2025 | |
| ONO PHARMACEUTICAL | 12,900 | 0,44 | +3,41 % | 40,00 | 30.03.2026 | |
| EISAI | 26,050 | 0,88 | +3,38 % | 80,00 | 30.03.2026 | |
| ASTELLAS PHARMA | 12,970 | 0,43 | +3,32 % | 39,00 | 30.03.2026 | |
| GSK | 23,500 | 0,76 | +3,23 % | 0,18 | 19.02.2026 |